| Literature DB >> 35233066 |
Margarita Cigarán-Méndez1, Edurne Úbeda-D'Ocasar2, José Luis Arias-Buría3, César Fernández-de-Las-Peñas3, Gracia María Gallego-Sendarrubias2, Juan Antonio Valera-Calero4,5.
Abstract
Previous studies have reported the presence of muscle weakness in women with fibromyalgia syndrome (FMS) which is considered a risk factor for developing earlier disability and dependence during activities of daily life (ADL). We aimed to assess the relationship between hand grip force with sociodemographic, clinical, disease-specific, cognitive, and physical function variables in women with FMS. One hundred twenty-six women with FMS completed demographic (age, gender, height, weight, body mass index), pain-related (pain history, pain intensity at rest and during ADL), disease-specific severity (Fibromyalgia Impact Questionnaire -FIQ-S-, Fibromyalgia Health Assessment Questionnaire -FHAQ-, EuroQol-5D, Pain Catastrophizing Scale -PCS-, Pittsburgh Sleep Quality Index-PSQI-, Pain Vigilance and Awareness Questionnaire -PVAQ-, and Central Sensitization Inventory -CSI-), psychological (Tampa Scale for Kinesiophobia, TKS-11; Pain Vigilance and Awareness Questionnaire, PVAQ; Pain Catastrophizing Scale, PCS), and physical function (hand grip force, and Timed Up and Go Test, TUG). Hand grip force was associated with height (r = -0.273), BMI (r = 0.265), worst pain at rest (r = -0.228), pain during ADL (r = -0.244), TUG (r = -0.406), FHAQ (r = -0.386), EuroQol-5D (r = 0.353), CSI (r = -0.321) and PSQI (r = -0.250). The stepwise regression analysis revealed that 34.4% of hand grip force was explained by weight (6.4%), TUG (22.2%), and FHAQ (5.8%) variables. This study found that hand grip force is associated with physical function indicators, but not with fear-avoidance behaviors nor pain-related features of FMS. Hand grip force could be considered as an easy tool for identifying the risk of fall and poorer physical health status.Entities:
Mesh:
Year: 2022 PMID: 35233066 PMCID: PMC8888740 DOI: 10.1038/s41598-022-07480-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Scatter plot of the adjusted predicted score (r2 adjusted: 0.344) explaining Hand Grip Force score in female patients with fibromyalgia syndrome.
Baseline outcomes (mean ± SD) of the sample.
| Baseline variable | Female patients with FMS ( |
|---|---|
| Age (years) | 52.0 ± 10.7 |
| Height (m) | 1.61 ± 0.06 |
| Weight (kg) | 71.4 ± 16.6 |
| Body mass index (kg/cm2) | 27.5 ± 6.2 |
| Years of pain (years) | 20.1 ± 15.3 |
| Years with FMS (years) | 10.2 ± 8.9 |
| Mean pain at rest (0–10) | 6.4 ± 1.7 |
| Worst pain at rest (0–10) | 7.3 ± 2.2 |
| Pain during daily activities (0–10) | 8.1 ± 1.9 |
| Time up and go test (seconds) | 12.4 ± 4.9 |
| Fibromyalgia impact questionnaire (0–100) | 64.8 ± 12.7 |
| Fibromyalgia health assessment questionnaire (0–3) | 1.3 ± 0.6 |
| EuroQol-5D questionnaire (0–100) | 0.41 ± 0.25 |
| Central sensitization inventory (0–100) | 70.7 ± 11.6 |
| Pain vigilance and awareness questionnaire (0–45) | 27.0 ± 8.2 |
| Pain catastrophizing scale (0–52) | 22.5 ± 12.3 |
| Tampa scale for kinesiophobia TSK-11 (0–44) | 24.9 ± 7.5 |
| Pittsburgh sleeping quality index (0–21) | 13.8 ± 3.9 |
| Mean | 16.7 ± 6.2 |
| Non-dominant hand | 16.5 ± 6.4 |
| Dominant hand | 17.1 ± 6.4 |
*No side-to-side differences (p = 0.494).
Pearson-product moment correlation matrix between sociodemographic, physical and clinical characteristics.
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
|---|---|---|---|---|---|---|---|---|---|
| 1. Age | |||||||||
| 2. Weight | n-s | ||||||||
| 3. Height | -.190* | .278** | |||||||
| 4. BMI | n-s | .948** | n-s | ||||||
| 5. Years with pain | .566* | n-s | -.220* | n-s | |||||
| 6. Years with FMS | .598** | n-s | n-s | n-s | .615** | ||||
| 7. Mean pain at rest | n-s | n-s | n-s | n-s | n-s | n-s | |||
| 8. Worst pain at rest | n-s | n-s | n-s | n-s | n-s | n-s | .427** | ||
| 9. PADL | n-s | n-s | n-s | n-s | n-s | n-s | .302** | n-s | |
| 10. TUG | .190* | .233** | n-s | .251** | n-s | n-s | n-s | n-s | .297** |
| 11. FIQ | -.199* | n-s | n-s | n-s | n-s | n-s | .421** | .272** | .422* |
| 12. FHAQ | n-s | .178* | n-s | .202* | n-s | n-s | .251** | n-s | .466** |
| 13. EQ5D | n-s | n-s | n-s | n-s | n-s | n-s | -.320** | -.217* | -.396** |
| 14. CSI | -.262** | n-s | n-s | n-s | n-s | n-s | .305** | .249** | .398** |
| 15. PVAQ | n-s | n-s | n-s | n-s | n-s | n-s | .316** | .234* | .210* |
| 16. PCS | n-s | n-s | n-s | n-s | n-s | n-s | .258** | .184* | .385** |
| 17. TSK11 | n-s | .244** | n-s | .218* | n-s | n-s | n-s | n-s | .344** |
| 18. PSQI | -.202* | n-s | n-s | n-s | -.189* | n-s | n-s | n-s | n-s |
| 19. Hand Grip Force | n-s | .273** | n-s | .265* | n-s | n-s | n-s | -.228* | -.244** |
BMI, Body Mass Index; CSI, Central Sensitization Inventory; EQ5D, EuroQol-5D Questionnaire; FHAQ, Fibromyalgia Health Assessment Questionnaire; FIQ, Fibromyalgia Impact Questionnaire; FMS, Fibromyalgia syndrome; PCS, Pain Catastrophizing Scale; PDDA, Pain during activities of daily life; PSQI, Pittsburgh Sleeping Quality Index; PVAQ, Pain Vigilance and Awareness Questionnaire; TSK-11, Tampa Scale for Kinesiophobia; TUG, Time Up and Go test.
*P < 0.05; **P < 0.01.
Summary of the stepwise regression analyses to determine predictors of hand grip force.
| Predictor outcome | Β | SE B | 95% CI | β | t | ||
|---|---|---|---|---|---|---|---|
| Hand grip force | Step 1 | ||||||
| Weight | .109 | .040 | .029; .188 | .273 | 2.696 | .029 | |
| Step 2 | |||||||
| Weight | .147 | .036 | .076; .219 | .371 | 4.102 | < .001 | |
| Time up and go | -.672 | .125 | -.920; -.424 | -.486 | -5.380 | < .001 | |
| Step 3 | |||||||
| Weight | .147 | .034 | .079; .215 | .370 | 4.272 | < .001 | |
| Time up and go | -.513 | .131 | -.774; -.253 | -.372 | -3.916 | < .001 | |
| FHAQ | -3.062 | 1.030 | -5.109; -1.015 | -.277 | -2.973 | .004 | |
FHAQ, Fibromyalgia Health Assessment Questionnaire.
R2 adj. = .064 for step 1, R2 adj. = .286 for step 2, R2 adj. = .344 for step 3.